Post-Approval Regulatory Support: Best Practices to Maintain Compliance and Competitive Advantage
Effective post-approval regulatory support ensures sustained compliance, safety, and market advantage through monitoring, change control, labeling updates, vigilance, complaint handling, license management, PSURs, recall readiness, and GMP audits.
Essential Components of a Winning Medical Device Submission Strategy in North America (FDA and Health Canada)
A winning North American medical device submission strategy requires mastering FDA 510(k), PMA, and Health Canada processes, implementing ISO 13485 risk management, human factors engineering, cybersecurity, and leveraging FDA eSTAR…
North American Cosmetic Compliance Now: MoCRA, Canadian Hotlist, and State-Level Chemical Bans—Practical Steps for Market Entry
To enter the North American cosmetic market, comply with US MoCRA by registering products, ensuring safety, and following GMPs; meet Canadian bilingual labeling and Hotlist rules; and navigate state chemical…
How to Build a Tailored Regulatory Roadmap for Pharmaceutical Approvals in the US and Canada
This guide outlines creating customized regulatory roadmaps for US FDA and Health Canada pharmaceutical approvals, emphasizing tailored strategies, key milestones, eCTD publishing, and post-approval pharmacovigilance to ensure timely, compliant market…
Health Canada’s Updated NHP Framework: What Changed and How to Protect Your Business
Health Canada's updated NHP regulations enforce stricter labeling, GMP, site licence, and post-market rules, raising compliance risks and costs; partnering with experts like Arora 297 helps businesses adapt and maintain…
Best Practices for Building an Effective Medical Device Submission Strategy for the US FDA and Health Canada
Develop a clear FDA and Health Canada submission strategy by understanding 510(k), De Novo, PMA, and licensing pathways, ensuring robust clinical evidence, ISO compliance, risk management, bilingual labeling, and post-market…
From Silos to Synergy: A Practical Blueprint to Integrate Your QMS for Global Compliance
This blueprint guides integrating QMS for global compliance, emphasizing process harmonization, eQMS validation, regulatory navigation (FDA, EU MDR, GMP), robust RA/QA practices, CAPA, risk management, audit readiness, and training.
Post-Approval Compliance and Risk Management: What Every RA/QA Leader Must Control in the US and Canada
Post-approval compliance in the US and Canada demands robust risk management, pharmacovigilance, complaint handling, and QMS aligned with FDA and Health Canada standards to ensure audit readiness and product safety.
